The journey of a new therapeutic drug coming to the marketplace is a complex and lengthy process that typically involves several key stages. The final part of our discussion focuses on the processes that occur after regulatory approval, including market access and post-market activities.
Continue readingClinical Trials – Discovery & Research in Action (Part 2 of 3)
The journey of a new therapeutic drug coming to the marketplace is a complex and lengthy process that typically involves several key stages. In the second part of our discussion, we’ll delve into the crucial stage of clinical trials, where drug candidates are tested in humans.
Continue readingDrug Discovery and Preclinical Research (3-part series)
The journey of a new therapeutic drug coming to the marketplace is a complex and lengthy process that typically involves several key stages. The first part of this discussion will focus on the initial phases, including drug discovery and preclinical research.
Continue readingIndustry News: Brain MRI surveillance needed for TKl-treated ALK or ROS7-positive NSCLC
Retrospective data showed how common central nervous system metastases are among patients with non-small cell lung cancer and ALK or ROS1 alterations who have been treated with tyrosine kinase inhibitors.
Continue readingIndustry News: Completion of Enrollment in Pivotal Phase 3 Trial of TAVT-45 for the Treatment of Metastatic Prostate Cancer
Novel Oral Suspension Formulation of Abiraterone Acetate Designed to Address Needs of Metastatic Prostate Cancer Patients Who Have Difficulty Swallowing (Dysphagia), an Issue for 20 to 30 Percent of Prostate Cancer Patients
Continue readingIndustry News: Two new studies substantiate prune’s role in bone health and digestive health
More than a simple snack, prunes have achieved superfood status due to their known benefits on bone, digestive, and cardiovascular health. Now, two new studies add further evidence to confirm the positive role that prunes have on overall health.
Continue readingIndustry News: Study Reveals Comedy, AI, and Self-Care Can Quickly Boost Patient Mental Health
In just eight weeks during the pandemic, women living with advanced cancer, ages 31 to 74, reported feeling more empowered, and less depressed, stressed, and anxious while using artificial intelligence to create personalized self-care plans infused with comedy and other relaxation techniques.
Continue readingIndustry News: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut microbiome could be an important factor in stroke risk and outcomes.
Continue readingIndustry News: Günenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis
The investigational medicine is being developed with the aim of providing patients suffering from pain associated with osteoarthritis with a well-tolerated, non-opioid therapy option that is intended to provide long-lasting pain relief and functional improvement of the affected joints.
Continue readingIndustry News: New Study Shows DCT Methods Helped Lung Cancer Trial Enrollment as COVID Surged
Remote and flexible trial approaches have been a hallmark of clinical trials during the pandemic and are widely believed to have been the primary factor in keeping trials open and operating. There is evidence showing that such measures as telehealth visits, off-site diagnostic/monitoring procedures and remote consenting were at least partially responsible for the ability of lung cancer trials to weather the storm.
Continue reading